{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:41:49Z","timestamp":1788183709181,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.acvd.2017.03.011","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T09:31:17Z","timestamp":1509787877000},"page":"41-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Nox4 genetic inhibition in experimental hypertension and metabolic syndrome"],"prefix":"10.1016","volume":"111","author":[{"given":"Ghina","family":"Bouabout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Ayme-Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Champy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Birling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Madeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lahcen El","family":"Fertak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Petit-Demouli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Sorg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-6900","authenticated-orcid":false,"given":"Yann","family":"Herault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mudgett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Monassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2017.03.011_bib0190","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2014.07.046","article-title":"Nox family NADPH oxidases: molecular mechanisms of activation","volume":"76","author":"Brandes","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.acvd.2017.03.011_bib0195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng0295-202","article-title":"Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production","volume":"9","author":"Pollock","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.acvd.2017.03.011_bib0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tips.2016.01.006","article-title":"Nox\/Duox family of NADPH oxidases: lessons from knockout mouse models","volume":"37","author":"Sirokmany","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.acvd.2017.03.011_bib0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.14336\/AD.2014.0305","article-title":"Metabolic syndrome, aging and involvement of oxidative stress","volume":"6","author":"Bonomini","year":"2015","journal-title":"Aging Dis"},{"key":"10.1016\/j.acvd.2017.03.011_bib0210","doi-asserted-by":"crossref","first-page":"181643","DOI":"10.1155\/2015\/181643","article-title":"Molecular events linking oxidative stress and inflammation to insulin resistance and beta-cell dysfunction","volume":"2015","author":"Keane","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.acvd.2017.03.011_bib0215","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.111.243972","article-title":"Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system","volume":"110","author":"Lassegue","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2017.03.011_bib0220","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.RES.0000187457.24338.3D","article-title":"NAD(P)H oxidase\u00a04 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts","volume":"97","author":"Cucoranu","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2017.03.011_bib0225","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.febslet.2005.12.049","article-title":"Decreased blood pressure in NOX1-deficient mice","volume":"580","author":"Gavazzi","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.acvd.2017.03.011_bib0230","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/CS20150404","article-title":"Nox1 in cardiovascular diseases: regulation and pathophysiology","volume":"130","author":"Gimenez","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.acvd.2017.03.011_bib0235","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00424-010-0790-8","article-title":"Hydrogen peroxide as an endothelium-derived hyperpolarizing factor","volume":"459","author":"Shimokawa","year":"2010","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.acvd.2017.03.011_bib0240","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bjp.0706423","article-title":"Hydrogen peroxide is an endothelium-dependent contracting factor in rat renal artery","volume":"146","author":"Gao","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.acvd.2017.03.011_bib0245","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.freeradbiomed.2012.06.027","article-title":"Role of Nox4 in murine models of kidney disease","volume":"53","author":"Babelova","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.acvd.2017.03.011_bib0250","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/CIRCRESAHA.112.267054","article-title":"Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase","volume":"110","author":"Schr\u00f6der","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2017.03.011_bib0255","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1681\/ASN.2013070810","article-title":"Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy","volume":"25","author":"Jha","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.acvd.2017.03.011_bib0260","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/1526-968X(200011\/12)28:3\/4<106::AID-GENE30>3.0.CO;2-T","article-title":"Widespread recombinase expression using FLPeR (flipper) mice","volume":"28","author":"Farley","year":"2000","journal-title":"Genesis"},{"key":"10.1016\/j.acvd.2017.03.011_bib0265","doi-asserted-by":"crossref","first-page":"e100102","DOI":"10.1371\/journal.pone.0100102","article-title":"Impact of Nox5 polymorphisms on basal and stimulus-dependent ROS generation","volume":"9","author":"Wang","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.acvd.2017.03.011_bib0270","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cellsig.2015.11.013","article-title":"Regulation of cellular oxidative stress and apoptosis by G protein-coupled receptor kinase-2; the role of NADPH oxidase\u00a04","volume":"28","author":"Theccanat","year":"2016","journal-title":"Cell Signal"},{"key":"10.1016\/j.acvd.2017.03.011_bib0275","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/ATVBAHA.108.181610","article-title":"NADPH oxidases: functions and pathologies in the vasculature","volume":"30","author":"Lassegue","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.acvd.2017.03.011_bib0280","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.vph.2012.02.012","article-title":"Targeting NADPH oxidases in vascular pharmacology","volume":"56","author":"Schramm","year":"2012","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.acvd.2017.03.011_bib0285","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tem.2014.06.012","article-title":"Endothelial NADPH oxidases: which NOX to target in vascular disease?","volume":"25","author":"Drummond","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.acvd.2017.03.011_bib0290","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/CIRCULATIONAHA.105.538934","article-title":"Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice","volume":"112","author":"Dikalova","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2017.03.011_bib0295","doi-asserted-by":"crossref","first-page":"F344","DOI":"10.1152\/ajprenal.00515.2013","article-title":"Enhanced expression and activity of Nox2 and Nox4 in the macula densa in ANG II-induced hypertensive mice","volume":"306","author":"Zhang","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.acvd.2017.03.011_bib0300","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","article-title":"NADPH oxidase\u00a04 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NFkappaB signaling pathways","volume":"131","author":"Zhao","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2017.03.011_bib0305","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/HYPERTENSIONAHA.109.140087","article-title":"Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin\u00a0II","volume":"54","author":"Peterson","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.acvd.2017.03.011_bib0310","doi-asserted-by":"crossref","first-page":"H733","DOI":"10.1152\/ajpheart.00873.2011","article-title":"PVN adenovirus-siRNA injections silencing either NOX2 or NOX4 attenuate aldosterone\/NaCl-induced hypertension in mice","volume":"302","author":"Xue","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.acvd.2017.03.011_bib0315","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/ATVBAHA.110.219238","article-title":"Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo","volume":"31","author":"Ray","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.acvd.2017.03.011_bib0320","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/HYPERTENSIONAHA.114.04208","article-title":"Nicotinamide adenine dinucleotide phosphate oxidase-4-dependent upregulation of nuclear factor erythroid-derived 2-like\u00a02 protects the heart during chronic pressure overload","volume":"65","author":"Smyrnias","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.acvd.2017.03.011_bib0325","doi-asserted-by":"crossref","first-page":"15565","DOI":"10.1073\/pnas.1002178107","article-title":"NADPH oxidase\u00a04 (Nox4) is a major source of oxidative stress in the failing heart","volume":"107","author":"Kuroda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.acvd.2017.03.011_bib0330","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCRESAHA.112.279760","article-title":"Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy","volume":"112","author":"Matsushima","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2017.03.011_bib0335","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/01.RES.0000099504.30207.F5","article-title":"Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy","volume":"93","author":"Byrne","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2017.03.011_bib0340","doi-asserted-by":"crossref","first-page":"R2267","DOI":"10.1152\/ajpregu.00267.2007","article-title":"Baroreceptor reflex modulation by circulating angiotensin\u00a0II is mediated by AT1 receptors in the nucleus tractus solitarius","volume":"293","author":"Tan","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.acvd.2017.03.011_bib0345","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/HYPERTENSIONAHA.107.105551","article-title":"Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice","volume":"52","author":"Monassier","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.acvd.2017.03.011_bib0350","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1254\/jphs.09148FP","article-title":"NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models","volume":"111","author":"Cui","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.acvd.2017.03.011_bib0355","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1124\/jpet.110.170373","article-title":"Ezetimibe ameliorates cardiovascular complications and hepatic steatosis in obese and type\u00a02 diabetic db\/db mice","volume":"335","author":"Fukuda","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.acvd.2017.03.011_bib0360","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/ATVBAHA.112.301087","article-title":"Toll-like receptor\u00a04 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms\u00a01 and 4","volume":"33","author":"Liang","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.acvd.2017.03.011_bib0365","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3109\/10715762.2015.1067697","article-title":"The novel NADPH oxidase\u00a04 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL\/6 mice","volume":"49","author":"Anvari","year":"2015","journal-title":"Free Radic Res"},{"key":"10.1016\/j.acvd.2017.03.011_bib0370","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/ijo.2011.279","article-title":"Deficiency in the NADPH oxidase\u00a04 predisposes towards diet-induced obesity","volume":"36","author":"Li","year":"2012","journal-title":"Int J Obes (Lond)"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187521361730181X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187521361730181X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:44:32Z","timestamp":1761745472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187521361730181X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S187521361730181X"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2017.03.011","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nox4 genetic inhibition in experimental hypertension and metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2017.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}